Andrew J. Silver

Andrew J. Silver is an accomplished finance professional with extensive experience in corporate finance and accounting. Currently serving as Vice President of Corporate Finance at CRISPR Therapeutics since October 2018, Andrew has held several progressive roles within the company, including Executive Director and Senior Director of Reporting & Technical Accounting. Prior to this, experience at E&Y included serving as Senior Manager in Assurance Services, and earlier roles included Financial Analyst at Summit Partners and Public Accountant at Ernst & Young. Andrew holds a Master of Science in Accounting from the University of Connecticut and a Bachelor of Science in Finance, Accounting, and History from Boston College.